COMMUNIQUÉS West-GlobeNewswire

Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes
27/08/2026
Research Shows that Patients with PSVT Experience a Substantial Burden Between Episodes, with Negative Impacts on Anxiety, Daily Activities, Sleep, and Work MONTREAL and CHARLOTTE, N.C., Aug. 27, 2026 (GLOBE NEWSWIRE [...]
HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results
27/08/2026
Highlights of the second quarter include: Net income increased 10% to $65.6 million , and net income margin increased to 19% from 18% last year. Adjusted EBITDA increased 11% to $167.0 million , and Adjusted EBITDA [...]
Cardurion Pharmaceuticals Announces Late-Breaking Presentation of Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, in Heart Failure
27/08/2026
Results from two Phase 2 clinical trials assessing tovinontrine in both major types of chronic heart failure will be presented at the Heart Failure Society of America annual scientific meeting BURLINGTON, Mass., Aug. 27 [...]
Noah Medical Announces Collaboration to Advance Imaging in Robotic-Assisted Bronchoscopy
27/08/2026
Compatibility between the Galaxy™ System and premium GE HealthCare OEC C-arms reflects collaboration to expand access to advanced lung diagnostics SAN JOSE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Noah Medical today [...]
MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism
27/08/2026
Pivotal Phase 3 oPTimize trial design builds on positive Phase 2 Avail™ results and durable one-year clinical benefit Global registrational trial to enroll approximately 160 adults with HP to support once-weekly [...]
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)
27/08/2026
- Fast Track Designation follows encouraging Phase 1 data that were previously reported for R/R mCRC - - Potential Varseta-M monotherapy registrational study in R/R mCRC planned for initiation in 1H 2027 - SOUTH SAN [...]
Artelo Biosciences Announces Reverse Stock Split
27/08/2026
Shares Expected to Begin Trading on a Split-Adjusted Basis on August 31, 2026 SOLANA BEACH, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage [...]
SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform
27/08/2026
TAIPEI, Taiwan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited (“SL Science” or the “Company”) (NASDAQ: SLBT), a Taiwan-headquartered biomedical company specializing in innovative cellular and gene [...]
Rectify Pharmaceuticals Presents Discovery of Clinical Candidate RTY-406, a Novel Disease-Modifying Therapy for the Treatment of PSC at ACS Fall 2026 Meeting
27/08/2026
Presentation highlights the discovery and characterization of RTY-406, an oral, once-daily investigational therapy targeting the underlying drivers of disease in Primary Sclerosing Cholangitis (PSC) BOSTON, Aug. 27, [...]
Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany
27/08/2026
Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business Johns Hopkins Hospital, a world-renowned academic medical center, Places [...]
Alvotech to present at upcoming investor conferences in September
27/08/2026
REYKJAVIK, Iceland, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, [...]
Alvotech to present at upcoming investor conferences in September
27/08/2026
REYKJAVIK, ICELAND (August 27, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced [...]
Conavi Medical Reports Fiscal Third Quarter 2026 Results and Operational Highlights
27/08/2026
Net loss for Fiscal Q3 2026 was $6.3 million (Fiscal Q3 2025 - $3.6 million) reflecting continued investment in research and development activities of $4.4 million (Fiscal Q3 2025 - $3.2 million) Ended Fiscal Q3 2026 [...]
Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference
27/08/2026
PLYMOUTH MEETING, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the 2026 Cantor Global [...]
Biomerica Announces $2.23 Million Financing
27/08/2026
Financing priced at $1.60 with no warrants or discount B. Riley Principal Capital and B. Riley executives, as well as Biomerica's CEO and all members of Biomerica’s Board of Directors participated in the financing [...]
Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit
27/08/2026
Differentiated Profile versus RAS-Targeted Approaches Including Revolution Medicines’ Daraxonrasib MELBOURNE, Australia, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “ [...]
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
27/08/2026
NEW HOPE, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk- [...]
ICU Medical to Participate in Upcoming Investor Conferences
27/08/2026
SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the [...]
Ambros Therapeutics Announces Appointments of John C. Jacobs and Scott Robertson to Board of Directors
27/08/2026
SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Ambros Therapeutics, Inc., today announced the appointments of John C. Jacobs and Scott Robertson to its Board of Directors. Mr. Jacobs is a seasoned industry leader with [...]

Pages